These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26782924)

  • 21. Alternative secretory signal sequences for recombinant protein production in Pichia pastoris.
    Karaoğlan M
    Enzyme Microb Technol; 2023 Aug; 168():110256. PubMed ID: 37196384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained and cancer cell targeted cytosolic delivery of Onconase results in potent antitumor effects.
    Zhao HL; Xue C; Du JL; Ren M; Xia S; Cheng YG; Liu ZM
    J Control Release; 2012 May; 159(3):346-52. PubMed ID: 22715504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy.
    Newton DL; Xue Y; Boqué L; Wlodawer A; Kung HF; Rybak SM
    Protein Eng; 1997 Apr; 10(4):463-70. PubMed ID: 9194172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of chain termini to the conformational stability and biological activity of onconase.
    Notomista E; Catanzano F; Graziano G; Di Gaetano S; Barone G; Di Donato A
    Biochemistry; 2001 Aug; 40(31):9097-103. PubMed ID: 11478876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stress.
    Ardelt B; Juan G; Burfeind P; Salomon T; Wu JM; Hsieh TC; Li X; Sperry R; Pozarowski P; Shogen K; Ardelt W; Darzynkiewicz Z
    Int J Oncol; 2007 Sep; 31(3):663-9. PubMed ID: 17671695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive comparison of the cytotoxic activities of onconase and bovine seminal ribonuclease.
    Matousek J; Soucek J; Slavík T; Tománek M; Lee JE; Raines RT
    Comp Biochem Physiol C Toxicol Pharmacol; 2003 Dec; 136(4):343-56. PubMed ID: 15012906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of dynamic effects on the enzyme activity: X-ray structure and molecular dynamics of onconase mutants.
    Merlino A; Mazzarella L; Carannante A; Di Fiore A; Di Donato A; Notomista E; Sica F
    J Biol Chem; 2005 May; 280(18):17953-60. PubMed ID: 15728177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB.
    Tsai SY; Ardelt B; Hsieh TC; Darzynkiewicz Z; Shogen K; Wu JM
    Int J Oncol; 2004 Dec; 25(6):1745-52. PubMed ID: 15547713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer.
    Lee I; Shogen K
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):337-46. PubMed ID: 18064463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective expression and purification of recombinant onconase, an antitumor protein.
    Notomista E; Cafaro V; Fusiello R; Bracale A; D'Alessio G; Di Donato A
    FEBS Lett; 1999 Dec; 463(3):211-5. PubMed ID: 10606723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effective expression of ribonuclease-onconase in Escherichia coli and assaying its cytotoxic potential].
    Xu GF; Wang QC; Gong XG; Fei J
    Shi Yan Sheng Wu Xue Bao; 2004 Jun; 37(3):227-31. PubMed ID: 15323425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of immuno-RNase may improve cancer therapy.
    Sun M; Sun L; Sun D; Zhang C; Li M
    Cancer Cell Int; 2018; 18():58. PubMed ID: 29686536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive expression of a rhIL-2-HSA fusion protein in Pichia pastoris using glucose as carbon source.
    Guan B; Chen F; Lei J; Li Y; Duan Z; Zhu R; Chen Y; Li H; Jin J
    Appl Biochem Biotechnol; 2013 Dec; 171(7):1792-804. PubMed ID: 23999737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of structural peculiarities of onconase to its high stability and folding kinetics.
    Arnold U; Schulenburg C; Schmidt D; Ulbrich-Hofmann R
    Biochemistry; 2006 Mar; 45(11):3580-7. PubMed ID: 16533040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-CD22 Onconase: preparation and characterization.
    Newton DL; Stockwin LH; Rybak SM
    Methods Mol Biol; 2009; 525():425-43, xiv. PubMed ID: 19252847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections.
    Menegazzi M; Gotte G
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onconase: an unusually stable protein.
    Notomista E; Catanzano F; Graziano G; Dal Piaz F; Barone G; D'Alessio G; Di Donato A
    Biochemistry; 2000 Aug; 39(30):8711-8. PubMed ID: 10913282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onconase cytotoxicity relies on the distribution of its positive charge.
    Turcotte RF; Lavis LD; Raines RT
    FEBS J; 2009 Jul; 276(14):3846-57. PubMed ID: 19523116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon enhances the activity of the anticancer ribonuclease, onconase.
    Vasandani VM; Castelli JC; Hott JS; Saxena S; Mikulski SM; Youle RJ
    J Interferon Cytokine Res; 1999 May; 19(5):447-54. PubMed ID: 10386856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression, purification and biological characterization of human vasostatin120-180 in Pichia pastoris.
    Lin Y; Yang X; Lu M; Zhuang H; Hua ZC
    Protein Expr Purif; 2013 Dec; 92(2):141-7. PubMed ID: 24096091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.